CompletedNCT00285818
Mifepristone added to electroconvulsive therapy for depression
About this title
Read the official source — NCT00285818Medication studyAges 18–75United States
Understand this study
Who was this study for?
This study was for people with depression. Listed age limits: 18 years to 75 years. Other eligibility criteria applied.
- Listed locations
- StanfordSee all locations and recruitment
Study information
Study start dateJanuary 2003
- Recruitment status
- Completed
- Enrollment listed in the registry
- 11
- Sponsor
- Stanford University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Locations
- United States
- Age range
- From 18 Years to 75 Years
- Official registry ID
- NCT00285818
- Official title
Show the full official title
A Double-blind, Placebo-controlled Study of Mifepristone in Patients With Non-psychotic Major Depressive Disorder Referred for Bilateral Electroconvulsive Therapy (ECT)
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Stanford
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Stanford University, a university.
Did this study involve medication?
Yes. The study involved medication, including Mifepristone and Placebo Oral Capsule.
Who was this study for?
This study was for people with depression. Listed age limits: 18 years to 75 years. Other eligibility criteria applied.
